AI-driven drug discovery platform that uses deep learning to predict which molecules will be effective medicines, dramatically accelerating the pharmaceutical research process. Atomwise applies convolutional neural networks to analyze molecular interactions and identify promising drug candidates in days rather than months or years. The platform has enabled breakthroughs in treatments for diseases like multiple sclerosis, cancer, and infectious diseases by analyzing millions of potential compounds and predicting their therapeutic effectiveness and safety profiles.
